Cubist Systematic Strategies, LLC Agios Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $81,217 - $99,763	4,067 New	4,067 $90,000
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $698,575 - $1.22 Million	35,806 Added 331.94%	46,593 $1.32 Million
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $184,026 - $338,927	10,787 New	10,787 $239,000
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $1.79 Million - $2.33 Million	-67,029 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $1.52 Million - $2.55 Million	51,323 Added 326.77%	67,029 $2.2 Million
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $523,706 - $726,842	12,493 Added 388.83%	15,706 $725,000
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $3.43 Million - $4.04 Million	-65,903 Reduced 95.35%	3,213 $177,000
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $310,361 - $403,477	-7,017 Reduced 9.22%	69,116 $3.57 Million
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $2.33 Million - $3.26 Million	-70,139 Reduced 47.95%	76,133 $3.3 Million
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $4.82 Million - $7.96 Million	142,311 Added 3592.8%	146,272 $5.12 Million
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $291,309 - $452,226	-8,456 Reduced 68.1%	3,961 $212,000
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $391,383 - $668,158	12,417 New	12,417 $441,000
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $1.73 Million - $2.92 Million	-57,675 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $1.23 Million - $1.89 Million	38,039 Added 193.72%	57,675 $1.87 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $906,594 - $1.34 Million	19,636 New	19,636 $979,000
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $901,225 - $1.33 Million	-19,626 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $822,894 - $1.47 Million	19,258 Added 5233.15%	19,626 $905,000
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $56,045 - $71,904	-782 Reduced 68.0%	368 $28,000
Q2 2018 Aug 14, 2018	BUY	$73.22 - $99.55 $69,559 - $94,572	950 Added 475.0%	1,150 $97,000
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $5,983 - $8,653	100 Added 100.0%	200 $16,000
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $119,406 - $165,708	-2,291 Reduced 95.82%	100 $6,000
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $131,241 - $160,483	2,391	2,391 $160,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$335 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$328 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$287 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$221 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$167 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account